ProQR Therapeutics N.V. (PRQR) Q3 2026 earnings results
ProQR Therapeutics N.V. (PRQR) reported EPS of -$0.10 against an analyst estimate of -$0.11: a beat of $0.01 (6.1%). The quarter ended Sep 30, 2026; the company reported on Thursday, November 19, 2026.
Status: Confirmed · 06:00 ET, Nov 19 · Source: EODHD (calendar and fundamentals, cross-checked)
Get an email before and after ProQR Therapeutics N.V. reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountPRQR Q3 2026 results at a glance
| EPS reported | -$0.10 |
|---|---|
| EPS estimate | -$0.11 |
| Surprise | Beat · +$0.01 (+6.1%) |
| Quarter ended | Sep 30, 2026 |
| Reported | Nov 19, 2026 |
| Status | Confirmed · 06:00 ET, Nov 19 |
EPS is as supplied by EODHD, in US dollars per share; whether it is adjusted or GAAP follows that source. This is ProQR Therapeutics N.V.’s Q3 2026, a calendar-year company.
ProQR Therapeutics N.V. EPS surprise history: last 5 quarters
ProQR Therapeutics N.V. beat the EPS estimate in 5 of its last 5 reports, with an average surprise of +25.4%.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Nov 19, 2026 | -$0.11 | -$0.10 | +6.1% | Beat | – |
| Aug 13, 2026 | -$0.18 | -$0.09 | +50.0% | Beat | +3.2% |
| May 12, 2026 | -$0.18 | -$0.15 | +16.7% | Beat | -0.6% |
| Mar 12, 2026 | -$0.12 | -$0.09 | +25.0% | Beat | +0.6% |
| Nov 6, 2025 | -$0.17 | -$0.12 | +29.4% | Beat | -7.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it. It is filled in a few trading days after each report.
PRQR stock reaction to the report
The price reaction will be added after the Nov 20, 2026 close.
This section appears once a post-report closing price exists and updates with every new close.
Next PRQR earnings report
ProQR Therapeutics N.V. has not announced its next earnings date yet. This page shows a date only once it is confirmed. See the PRQR earnings calendar.
ATLAS fair value and signal for PRQR
| Last price | $1.05 (-4.6%) |
|---|---|
| Chance of a higher close in 1 month | 45% (normal range $0.88–$1.19) |
These are model outputs from the same valuation and calibrated model as the ProQR Therapeutics N.V. stock page. They describe an ordinary period and are not a forecast of any particular outcome.
ProQR Therapeutics N.V. Q3 2026 earnings: frequently asked questions
Did ProQR Therapeutics N.V. beat earnings estimates for Q3 2026?
ProQR Therapeutics N.V. reported EPS of -$0.10 against an analyst estimate of -$0.11: a beat of $0.01 (6.1%).
When did ProQR Therapeutics N.V. report Q3 2026 results?
ProQR Therapeutics N.V. reported on Thursday, November 19, 2026, for the quarter ended Wednesday, September 30, 2026.
How often does PRQR beat EPS estimates?
In its last 5 reports with a recorded result, ProQR Therapeutics N.V. beat the EPS estimate 5 times; the average surprise was +25.4%. Past results do not predict the next one.
How does ATLAS confirm a result?
A result is published only after it is cross-checked: the EODHD earnings calendar and the EODHD fundamentals feed must show the same EPS for the same fiscal period, or the same value must appear in two consecutive checks. Unconfirmed figures are never published. If the figures are revised later, this page updates.
Educational information, not investment advice. Disclaimer